Staphylococcus capitis isolated from bloodstream infections: a nationwide 3-month survey in 38 neonatal intensive care units

Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2185-2194. doi: 10.1007/s10096-020-03925-5. Epub 2020 Jun 9.

Abstract

To increase the knowledge about S. capitis in the neonatal setting, we conducted a nationwide 3-month survey in 38 neonatal intensive care units (NICUs) covering 56.6% of French NICU beds. We demonstrated 14.2% of S. capitis BSI (S.capBSI) among nosocomial BSIs. S.capBSI incidence rate was 0.59 per 1000 patient-days. A total of 55.0% of the S.capBSIs were late onset catheter-related BSIs. The S. capitis strains infected preterm babies (median gestational age 26 weeks, median birth weight 855 g). They were resistant to methicillin and aminoglycosides and belonged to the NRCS-A clone. Evolution was favorable in all but one case, following vancomycin treatment.

Keywords: Bloodstream catheter-related infection; NRCS-A clone; Nationwide active surveillance; Neonatal Intensive Care Unit (NICU); Neonates; Preterm babies; Staphylococcus capitis.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Catheter-Related Infections / drug therapy
  • Catheter-Related Infections / epidemiology
  • Catheter-Related Infections / etiology
  • Drug Resistance, Multiple, Bacterial
  • Female
  • France / epidemiology
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Intensive Care Units, Neonatal
  • Male
  • Sepsis / drug therapy
  • Sepsis / epidemiology*
  • Sepsis / etiology
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / etiology
  • Staphylococcus capitis / drug effects
  • Staphylococcus capitis / isolation & purification*

Substances

  • Anti-Bacterial Agents